Global Cord Blood (NYSE:CO) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell?

Key Points

• Global Cord Blood's stock price crossed above its 200-day moving average during trading, reaching a high of $1.40 and last trading at $1.40, indicating positive momentum.
• Wall Street Zen has initiated coverage on the company with a "strong-buy" rating, suggesting strong confidence in its future performance.
• The company has a current market cap of $170.17 million and a price-to-earnings ratio of 2.19, reflecting its valuation metrics.

Global Cord Blood Co. (NYSE:CO - Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.98 and traded as high as $1.40. Global Cord Blood shares last traded at $1.40, with a volume of 11,665 shares.

Analysts Set New Price Targets

Separately, Wall Street Zen initiated coverage on shares of Global Cord Blood in a research note on Saturday, May 17th. They set a "strong-buy" rating for the company.

Global Cord Blood Price Performance

The firm has a market capitalization of $194.48 million, a P/E ratio of 2.50 and a beta of 0.16. The business's 50-day moving average is $1.03 and its 200 day moving average is $0.99.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.